Desempenho financeiro do varejo farmacêutico no contexto pandêmico: uma análise das empresas Raia Drogasil S.A e Empreendimentos Pague Menos S.A.

Abstract

In view of the sanitary and economic crisis caused by COVID-19 and its consequences for Brazilian companies, this paper seeks to analyze two of the largest retail companies in the country, Raia Drogasil SA and Empreendimento Pague Menos SA, with the aim of to identify the impacts of the pandemic on the financial performance of these companies, therefore, we sought to analyze the results of organizations in the periods from 2016 to 2020. As for the type of research, it is framed as bibliographic and documentary research, in relation to the objectives, if as descriptive and the method of approach is quali-quantitative. The evaluation was carried out based on the values extracted from the Balance Sheet and the Income Statement for the Year, the financial indicators used were current liquidity, debt composition and leverage, and to measure economic performance, the ROA variables were used, which is capacity of generating profits from the investment in assets, and the ROE that measures the returns of the shareholders' investments. The results show that companies obtained good financial results in relation to current liquidity and debt composition, but having a worrying situation in leverage, as for economic indices, there was a drop in these indices over the analyzed period, which reduced the generation of gains on assets and return on capital invested by shareholders, the results revealed that the pandemic caused an increase in sales of pharmaceutical products in 2020, and consequently the growth of companies in this sector.